COVID-19 updates, including vaccine information, for our patients and visitors Learn More
View All Releases >
University of California San Diego School of Medicine and Moores Cancer Center researchers report that intermittent fasting reduced breast cancer risk in obese mice.
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive ...
University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Sciences researchers report that starting tobacco products, including e-cigarettes, before the age of 18 ...
Chemicals used for vaping break down zipper-like junctions between cells in the gut, leading to chronic inflammation and potential for other health concerns.
View All Features >
The team at UC San Diego Health takes a family centered approach to treating children for burns that ensures the social, emotional and psychological needs are met for pediatric patients and their fami ...
María Madrigal, receptora de riñón donante, estaba plagada de bacterias multirresistentes; un tratamiento emergente llamado terapia con bacteriófagos resultó ser el remedio.
Donor kidney recipient Maria Madrigal was plagued by multidrug-resistant bacteria; an emerging treatment called phage therapy proved to be the remedy.
Convalescent therapy is a century-old approach adapted to potentially treating and preventing COVID-19 by boosting patients’ neutralizing antibodies. Edward Cachay, MD, leads a clinical trial at UC Sa ...
In the News
View More >
Features Christopher Longhurst, MD, CIO, ACMO, and Davey Smith, MD
Features Leslie Crews, PhD, and Catriona Jamieson, MD, PhD
Features Robert Coles, MD
Features John Pierce, PhD (Emeritus)
Features Steffanie Strathdee, PhD